1. Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-Asparaginase conjugates;Abuchowski;Cancer Biochem. Biophys.,1984
2. The occurrence, induction, specificity and potential effect of antibodies against poly(ethylene glycol);Armstrong,2009
3. Antibody against poly(ethylene glycol) adversely affects PEG-Asparaginase therapy in acute lymphoblastic leukemia patients;Armstrong;Cancer,2007
4. Comparative pharmacokinetic/pharmacodynamic characterisation of a new pegylated recombinant E. coli l-Asparaginase preparation (MC0609) in Beagle dog. Cancer Chemother;Borghorst;Pharmacology,2014
5. Antibody response to Escherichia coli l-asparaginase. Prognostic significance and clinical utility of antibody measurement;Cheung;Am. J. Pediatr. Hematol. Oncol.,1986